I've completed a monograph that calls for change in the addiction treatment arena. It focuses on our need to modify our settings and services to a tobacco-free and smoke-free model of care. This post is the fourth and final in a small series of excerpts from the monograph. The intent of posting these excerpts is … Continue reading Tobacco-free and smoke-free addiction treatment: monograph introduction # 4

I've completed a monograph that calls for change in the addiction treatment arena. It focuses on our need to modify our settings and services to a tobacco-free and smoke-free model of care. This post is the third in a small series of excerpts from the monograph. The intent of posting these excerpts is to build … Continue reading Tobacco-free and smoke-free addiction treatment: monograph introduction # 3

I've completed a monograph that calls for change in the addiction treatment arena. It focuses on our need to modify our settings and services to a tobacco-free and smoke-free model of care. This post is the second in a small series of excerpts from the monograph. The intent of posting these excerpts is to build … Continue reading Tobacco-free and smoke-free addiction treatment: monograph introduction # 2

I've completed a monograph that calls for change in the addiction treatment arena. It focuses on our need to modify our settings and services to a tobacco-free and smoke-free model of care. This post will serve as the first in a small series of excerpts from the monograph. The intent of posting these excerpts is … Continue reading Tobacco-free and smoke-free addiction treatment: monograph introduction

In case you missed it, on 07/17/2025 the FDA announced it has "authorized" the marketing of five JUUL e-cigarette products. These are the JUUL device, Virginia Tobacco flavor JUULpods (3% and 5% nicotine concentration) and Menthol flavor JUULpods (3% and 5% nicotine concentration). Give these quotes from the FDA announcement a read. Then I'll add … Continue reading JUUL E-Cigarette Products & the FDA

Did you know that a synthetic analog of nicotine has been developed and is on the market? It’s called 6-methyl nicotine (6-MN). Before we get into some of the more recent findings about 6-MN, it’s important to understand one specific term related to the research.  The term is “reactive oxygen species”, or ROS. Here’s the … Continue reading 6-methyl nicotine is here

A few days ago I posted a list of research-based findings concerning nicotine. The post was simply titled "Nicotine". One main point of that post was to ask, "On a scale from 0 to 10 how important is it to treat tobacco use in a patient with a substance use disorder? And why?" That post … Continue reading Pouch

My recent post titled “Nicotine” produced responses showing an interest in similar information about “vape”.  Below is a series of bottom-line findings from various papers on “vape” published from 2020 to current. The papers examine topics such as: the cellular effects of various vape ingredients, the impacts of second and third-hand vape exposures in the … Continue reading Vape

On a scale from 0 to 10 how important is it to treat tobacco use in a patient with a substance use disorder? And why? Smokers have a 30% - 40% higher risk of diabetes than non-smokers. U.S. Department of Health and Human Services. (2014).  The Health Consequences of Smoking—50 Years of Progress: A Report of … Continue reading Nicotine

In this post I'm highlighting a most incredible document recently published at the Preserving the Message website. The document is titled, "Chronology of Narcotics Anonymous Literature (Public Version) – Volume 1 (1953-1993)". It was published on 06/07/2025 and is simply amazing. For starters, I strongly encourage everyone to click the page that houses that document … Continue reading From the “Preserving the Message” website: “Chronology of Narcotics Anonymous Literature, Vol 1”